Skip to main content
Loading

ZWI Therapeutics

October 17, 2023
Franciscan B
Oncology
ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company’s proprietary polymer technology reduces the immunogenicity of therapeutic proteins and significantly improves the pharmacokinetics of the protein. ZWI has optimized the novel polymer and begun preclinical development of protein-based therapeutics using the polymer and demonstrating reduced immunogenicity.
Speakers
Ed Mascioli, CEO - ZWI Therapeutics

Company Type

Privately Funded

Website

https://zwitx.com/

CEO/Top Company Official

Ed Mascioli

Lead Product in Development

Uricase linked to a novel polymer

Number Of Unlicensed Products

Multiple as we are a product and platform company

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS